Question: Does sequence length matter for CNV and variants?
gravatar for Martin
9 months ago by
Martin0 wrote:

Hi, I am very new for NGS, so this question might be silly, recently I got my whole exome sequencing data for tumors and matched normal tissues, after run fastQC for my raw fastq files, I find the sequence length of some normal tissues are all 50-125, the other normal tissues and tumors are all 50-75, I think this affect the varients and CNV results, but I am not sure. Could anyone tell what will be the consequence? and why? Thanks

next-gen sequence • 310 views
ADD COMMENTlink modified 9 months ago by Chris Miller20k • written 9 months ago by Martin0
gravatar for Sean Davis
9 months ago by
Sean Davis25k
National Institutes of Health, Bethesda, MD
Sean Davis25k wrote:

For variants and CNV results, the differences in length of reads may not be substantial. However, if you have libraries that were prepared differently and are comparing them, spend some time looking at other metrics such as depth of sequencing, differential coverage (different exome kits and even batches of the same can have an impact), and duplication metrics. None of these will disqualify a library if it cannot be replaced, but some may be more problematic than others.

ADD COMMENTlink written 9 months ago by Sean Davis25k

The libraries from different patients were prepared together, and should be the OK, but it's true that my samples were sequenced by two different batches, I don't if there were any other differences for the two batches, I guess I have to contact the sequencing department and ask them, thanks for your comments.

ADD REPLYlink written 9 months ago by Martin0
gravatar for Chris Miller
9 months ago by
Chris Miller20k
Washington University in St. Louis, MO
Chris Miller20k wrote:

Yes, differences in mapability will likely cause a host of false positives when comparing samples with different read lengths. Having 125bp reads opens up a bunch of the genome where 50bp reads are not uniquely mapable. Comparing read depth of the two between a tumor and normal will likely cause problems.

That said, as long as the tumor and normal from the same patient is the same length, then I wouldn't be overly concerned about comparing across patients.

ADD COMMENTlink written 9 months ago by Chris Miller20k
Please log in to add an answer.


Use of this site constitutes acceptance of our User Agreement and Privacy Policy.
Powered by Biostar version 2.3.0
Traffic: 1649 users visited in the last hour